Fortive Earnings Call: Cash, Margins and Cautious Growth

Fortive ((FTV)) has held its Q4 earnings call. Read on for the main highlights of the call.

Fortive’s latest earnings call painted a broadly upbeat picture, as the company delivered accelerating revenue and double‑digit EPS growth, expanding EBITDA margins and strong free cash flow that more than covered net income. Management leaned into an optimistic narrative around recurring software and AI‑driven offerings, while underscoring disciplined capital returns through aggressive buybacks. Still, they acknowledged pressures from gross margins, tariffs, and hospital capital spending, as well as a deliberately cautious top‑line outlook that tempers the otherwise bullish tone.

Revenue and Core Growth Stabilize with Modest Acceleration

Fortive reported Q4 revenue of $1.1 billion, up just over 4.5% year over year on a reported basis and a little more than 3% on a core basis, signaling steady but not explosive growth. For the full year, reported revenue is expected to land near $4.3 billion, and management’s 2026 framework calls for core revenue growth of 2%–3%. That stance effectively signals confidence in continued expansion, but also embeds caution about the macro environment after a relatively strong fourth quarter.

Margin Expansion Underpins Profitability Story

Profitability remained a key strength. Q4 adjusted EBITDA climbed to $358 million, up roughly 8% versus last year, and the consolidated adjusted EBITDA margin widened by about 100 basis points to nearly 32%. Within this, the iOS segment (Intelligent Operating Solutions) delivered 8% adjusted EBITDA growth to $288 million and a margin just over 37%, also up about 100 basis points. This margin expansion narrative reinforces Fortive’s focus on mix, productivity, and scaling higher‑value solutions, even as some areas of the portfolio face headwinds.

EPS Beat Highlights Strong Operating Execution

Earnings outpaced expectations, reinforcing the positive tone. Fortive posted Q4 adjusted EPS of $0.90, up about 13% year over year, and full‑year adjusted EPS of $2.71, growing just over 12% and finishing above the prior guidance range of $2.63–$2.67. The beat reflects a mix of margin gains, cost discipline, and share repurchases, signaling that management is successfully converting operating performance into per‑share earnings growth.

Robust Cash Generation Fuels Aggressive Buybacks

Cash generation remains a central pillar of Fortive’s equity story. The company produced roughly $315 million of free cash flow in Q4 and about $930 million for the full year, with free cash flow conversion running above 100% of adjusted net income. Fortive deployed $265 million toward share repurchases in Q4 alone and about $1.3 billion in the second half of 2025, retiring around 26 million shares—roughly 8% of diluted shares outstanding—and buying an additional 2.5 million shares after quarter end. Management now models a diluted share count of around 315 million, meaning future EPS will benefit from a smaller base, though this also raises the importance of managing leverage and interest costs.

iOS Segment Delivers Solid Growth and Leverage

The iOS segment was a standout performer, with revenue growing just over 5% on a reported basis and about 4% on a core basis. Growth was driven by strong demand at Fluke—particularly in data centers and professional instrumentation—alongside momentum in gas detection solutions offered as hardware‑as‑a‑service and in facility and asset lifecycle software. iOS adjusted gross margin held just under 67%, and the segment demonstrated operating leverage as revenue growth translated into outsized EBITDA gains, reinforcing the strength of this more software‑ and solutions‑oriented portfolio.

Recurring Revenue, Software and AI Becoming Growth Engines

Management highlighted recurring revenue and software momentum as key long‑term drivers. Recurring revenue grew faster than the company’s overall top line in Q4, supported by maintenance software and the expanding use of embedded data and AI capabilities across both iOS and the AHS (Advanced Healthcare Solutions) segment. Fortive pointed to AI enhancements in offerings such as ServiceChannel and Fluke software, as well as strong annual recurring revenue growth, high retention, and positive net dollar expansion in its software franchises. This shift toward higher‑quality, subscription‑like revenue is central to Fortive’s strategy of building a more resilient, higher‑margin business model.

Gross Margin Pressure from Mix, Tariffs and Investment

Despite EBITDA margin expansion, the company saw notable gross margin pressure in the quarter. Consolidated adjusted gross margin fell about 150 basis points year over year to roughly 63%, driven by less favorable product mix, the net impact of tariffs and associated countermeasures, and targeted growth investments. iOS gross margin declined around 130 basis points, while AHS gross margin compressed to 56% from about 58% a year ago. Management framed these pressures as manageable and partly strategic, but they remain a watchpoint for investors tracking the quality of profitability.

AHS Faces Capital Equipment Headwinds and Margin Compression

The AHS segment delivered more muted performance, reflecting pressure in hospital capital spending. AHS revenue grew around 3% on a reported basis and 1.6% core, but was hampered by reimbursement and funding policy changes that pushed out U.S. hospital capital expenditures, particularly for equipment. This has weighed on equipment‑related revenue and prompted Fortive to reinvest strategically in the business, decisions that contributed to lower margins: Q4 adjusted EBITDA came in at $92 million, with AHS EBITDA margin at about 26%. While management views these investments as positioning AHS for future growth, investors will be watching for a recovery in hospital spending to restore momentum.

Tariffs and Cost Headwinds Remain a Background Risk

Tariffs and related cost actions were cited as a meaningful factor in the year’s margin dynamics. The net effect of tariffs and Fortive’s countermeasures weighed on margins in 2025 and were specifically called out as a driver of the Q4 gross margin decline. Looking ahead, management does not expect tariffs, net of countermeasures, to be a major drag on the 2026 bottom line, but they remain a structural risk factor that can influence product mix and pricing strategies.

Conservative Top-Line Guidance Versus Q4 Momentum

One of the more debated elements of the call is the apparent conservatism in Fortive’s 2026 growth outlook relative to recent trends. Q4 core growth of roughly 3% compares with 2026 core growth guidance of just 2%–3%, indicating management is not extrapolating the recent acceleration into the new year. This cautious stance likely reflects macro uncertainty and specific headwinds such as hospital capex, but it also sets up potential upside if demand holds or improves. For investors, the guidance suggests Fortive prefers to under‑promise on revenue while delivering through margin control, recurring revenue, and capital allocation.

Leverage and Interest Shape Capital Allocation Choices

Fortive exited the year with leverage at 2.6x gross debt to adjusted EBITDA—manageable, but a level that demands prudent balancing between buybacks, investment, and potential M&A. Management expects net interest expense of just over $120 million in 2026, a line item that has become more material after aggressive share repurchases. The company’s ability to sustain strong free cash flow while keeping leverage in check will be an important factor in how long it can maintain its current pace of capital returns.

Guidance: Steady Growth, Margin Expansion and FX Tailwinds

For 2026, Fortive guided to adjusted EPS of $2.90–$3.00 per share, implying about 9% year‑over‑year growth at the midpoint, anchored on a continuation of Q4 market conditions and current tariff rates. Management expects core revenue growth of 2%–3% on nearly $4.3 billion of reported revenue at current exchange rates, and models a diluted share count of roughly 315 million. The guidance incorporates a mid‑teens adjusted effective tax rate (higher in the first three quarters and lower in Q4), full‑year net interest expense just over $120 million, and an FX tailwind of about 300 basis points in Q1 that fades over the year. Importantly, Fortive reiterated its framework for 50–100 basis points of adjusted EBITDA margin expansion across 2026–2027, underscoring confidence that operational efficiency and mix shift can continue to lift profitability even on modest revenue growth.

Fortive’s earnings call reinforced the company’s transition toward a higher‑margin, software‑ and analytics‑driven portfolio, backed by strong cash generation and shareholder‑friendly capital allocation. While gross margin pressures, healthcare capital spending headwinds, and cautious revenue guidance inject some uncertainty, management’s consistent margin expansion, robust free cash flow, and recurring revenue momentum create a constructive setup for investors. Overall, the call suggested a business with solid fundamentals and clear levers for EPS growth, but one that must continue to execute through a mixed macro backdrop to fully deliver on its 2026 framework.